Ex parte DINSMORE et al. - Page 2



             Appeal No. 1999-1256                                                                                     
             Application No.  08/333,076                                                                              

             differentiation culture medium in the presence of every agent which promotes                             
             differentiation of the embryonic stem cells into every desired cell type.”); and page 3                  
             (“[I]t is not necessary that Applicants culture embryonic stem cells in the presence of                  
             every agent and every medium which would promote differentiation of the embryonic                        
             stem cells into every desired cell type.”).                                                              
                    Appellants analogize the instant claims to an invention “directed to the culture                  
             conditions for expression of recombinant protein in a certain cell.”  Page 2, second full                
             paragraph.  They argue that, in such a case, “the inventor need not enable one skilled in                
             the art to express a wide variety of proteins in order to be entitled to coverage of the                 
             inventive culture conditions for expression.”  Id.                                                       
                    To the extent that Appellants urge that the board applied an incorrect standard of                
             enablement to the claims on appeal, we disagree.  The appropriate legal standard for                     
             determining enablement was discussed and applied on pages 7 -8 of the decision                           
             entered July 30, 2001, which states:                                                                     
                    The specification discloses no agents that promote differentiation of                             
                    embryonic stem cells into cell types other than neuronal cells and muscle                         
                    cells.  In addition, the specification states that the prior art does not                         
                    disclose any agents that promote differentiation of embryonic stem cells                          
                    into a particular cell type.  See page 2 (“Differentiation of stem cells into a                   
                    homogeneous population, however, has not been achieved.”).                                        
                    Thus, the specification lacks working examples or detailed guidance                               
                    concerning the range of differentiation-promoting agents encompassed;                             
                    the scope of the claims encompasses using any differentiation promoting                           
                    agent to produce any type of cell; the prior art provides no guidance                             
                    regarding producing a specific cell type from embryonic stem cells; and                           
                    neither the prior art nor the specification provides any basis on which to                        
                    predict what type of cell will result from treatment with a given agent.                          

                                                          2                                                           





Page:  Previous  1  2  3  4  5  6  Next 

Last modified: November 3, 2007